Duodenoscopes are at the center of the Olympus endoscope litigation. If you or a loved one suffered a serious infection after a procedure involving an Olympus duodenoscope, you may qualify for a free case review.
A duodenoscope is a specialized, side-viewing flexible endoscope designed for Endoscopic Retrograde Cholangiopancreatography (ERCP). Unlike standard endoscopes that look straight ahead, duodenoscopes have a side-viewing camera and a complex elevator mechanism at the distal tip that helps guide instruments into the bile and pancreatic ducts.
The elevator mechanism is the critical design feature at issue in many Olympus duodenoscope lawsuit claims. This small mechanical component has recessed crevices that can trap biological material—blood, bile, tissue, and bacteria—making thorough cleaning between patients extremely difficult. Even when hospitals follow manufacturer-recommended reprocessing protocols, studies have shown that contamination can persist.
Olympus manufactures several duodenoscope models central to the litigation, including the TJF-Q180V, TJF-Q190V, and TJF-Q290V. These devices have been linked to superbug outbreaks at major hospitals across the United States, including incidents involving carbapenem-resistant Enterobacteriaceae (CRE) and other antibiotic-resistant organisms.
Why Olympus duodenoscopes are central to the lawsuit
Olympus Corporation dominates the duodenoscope market, controlling an estimated 85% of U.S. market share. The company's duodenoscopes have been linked to at least 41 superbug outbreaks across the country. The FDA issued multiple safety communications beginning in 2015, and in 2016 required manufacturers to conduct postmarket surveillance studies on the effectiveness of reprocessing instructions.
Plaintiffs in Olympus duodenoscope lawsuit claims allege the company knew about contamination risks associated with the elevator mechanism design but failed to adequately warn hospitals, patients, and regulators. Despite reports of patient infections, Olympus allegedly delayed issuing safety warnings and resisted design changes that could have reduced cross-contamination risk.
The litigation has expanded beyond individual lawsuits into multidistrict litigation (MDL) proceedings. Hospitals have also filed claims against Olympus for the costs of outbreak investigations, patient notifications, and remediation measures.
Injuries linked to contaminated duodenoscopes
Patients exposed to contaminated duodenoscopes during ERCP procedures have reported a range of serious and sometimes fatal injuries:
CRE (carbapenem-resistant Enterobacteriaceae) infections that resist most antibiotics
E. coli bacteremia and other Gram-negative bloodstream infections
Sepsis and septic shock requiring ICU admission
Cholangitis (bile duct infection) with prolonged hospitalization
Pancreatitis triggered or worsened by contaminated instruments
Multi-organ failure in severe infection cases
Death from overwhelming sepsis or complications of antibiotic-resistant infections
Legal theories in duodenoscope claims
Duodenoscope lawsuits typically pursue product liability claims including defective design (the elevator mechanism creates unavoidable contamination risk), failure to warn (inadequate instructions about reprocessing limitations), and manufacturing defects. Some claims also include negligence theories focused on Olympus's delayed response to outbreak reports.
Because duodenoscopes are at the epicenter of the Olympus endoscope litigation, these claims often have strong factual foundations supported by FDA safety communications, outbreak investigation reports, and internal company documents obtained through discovery.
Key evidence for duodenoscope claims
ERCP procedure records confirming use of an Olympus duodenoscope (look for model numbers TJF-Q180V, TJF-Q190V, or TJF-Q290V)
Positive cultures for CRE, ESBL, or other resistant organisms within 180 days of ERCP
Hospital notification letters about duodenoscope contamination or superbug exposure
Records of hospitalization, IV antibiotics, or ICU admission following your procedure
Discharge summaries and follow-up treatment records documenting infection resolution or ongoing complications
Primary sources
When researching infection risk, reprocessing, or regulatory history, verify facts using official agency materials. Summaries on this site are for education and intake screening, not medical or legal advice.
Reprocessing reusable medical devices — U.S. Food and Drug Administration. FDA hub for flexible endoscope reprocessing requirements, labeling, and safety communications.
For overlapping questions about screening, timelines, and how Top Tier Legal connects inquiries with counsel, see the Olympus endoscope lawsuit FAQ on the main practice page rather than duplicating those answers on every procedure page.
If your situation involves an Olympus duodenoscope procedure and a qualifying injury, start your free, confidential case review below.
Top Tier Legal, LLC is not a law firm and does not provide legal advice. Submitting information does not create an attorney-client relationship. If you qualify, we may connect you with an independent law firm.
